What is the recommended treatment for acute gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Gout

First-line treatment for acute gout includes NSAIDs, oral colchicine, or corticosteroids, which should be initiated within 24 hours of symptom onset for optimal outcomes. 1, 2

First-Line Treatment Options

NSAIDs

  • Use full FDA-approved anti-inflammatory doses until the gouty attack has completely resolved 1
  • FDA-approved NSAIDs for acute gout include naproxen (500mg twice daily), indomethacin, and sulindac 1, 3
  • Contraindicated in patients with renal disease, heart failure, or cirrhosis 1, 4
  • Associated with gastrointestinal toxicity, including risk of bleeding, ulceration, and perforation 4, 5

Colchicine

  • Most effective when started within 36 hours of symptom onset 6, 2
  • Recommended low-dose regimen: 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (maximum 1.8 mg over a one-hour period) 1, 7
  • Low-dose regimen is as effective as higher doses with fewer gastrointestinal side effects 1, 7
  • Common side effects include diarrhea, nausea, vomiting, cramps, and abdominal pain 1, 4
  • Contraindicated in patients with severe renal or hepatic impairment who are using potent CYP3A4 inhibitors or P-glycoprotein inhibitors 1, 7

Corticosteroids

  • Considered first-line therapy in patients without contraindications due to their safety profile and low cost 1, 2
  • Options include:
    • Oral: Prednisolone 30-35 mg daily for 3-5 days 1, 6
    • Intra-articular: Particularly effective for single joint involvement 6, 2
    • Intramuscular: Triamcinolone acetonide 60 mg 1
  • Contraindicated in patients with systemic fungal infections 1

Treatment Selection Considerations

Patient-Specific Factors

  • Renal function: Avoid NSAIDs and adjust colchicine dose in renal impairment 4, 7
  • Cardiovascular disease: Consider colchicine or corticosteroids over NSAIDs 4
  • Gastrointestinal risk: Avoid NSAIDs or use with gastroprotection 4
  • Diabetes: Use corticosteroids with caution due to potential hyperglycemia 1

Severity of Attack

  • For severe or polyarticular attacks, combination therapy may be appropriate 1, 4
  • Acceptable combination approaches include:
    • Colchicine and NSAIDs
    • Oral corticosteroids and colchicine
    • Intra-articular steroids with any other modality 1

Important Principles

  • Initiate treatment within 24 hours of symptom onset for best outcomes 1, 2
  • Continue urate-lowering therapy (if already prescribed) during the acute attack 1, 6
  • For inadequate response (defined as <20% improvement in pain score within 24 hours or <50% at ≥24 hours), consider adding a second agent 1
  • Continue treatment at full dose until the gouty attack has completely resolved 1

Common Pitfalls to Avoid

  • Delaying treatment initiation, which reduces effectiveness of all options 4, 2
  • Using high-dose colchicine regimens, which have similar efficacy but significantly more side effects than low-dose regimens 1, 7
  • Discontinuing urate-lowering therapy during acute flares 1, 2
  • Failing to adjust colchicine dosing in patients with renal impairment or those taking interacting medications 4, 7
  • Not considering drug interactions, particularly with colchicine 6, 7

Prophylaxis After Acute Attack

  • Prophylaxis is strongly recommended when starting urate-lowering therapy 1, 2
  • Options include:
    • Low-dose colchicine (0.6 mg once or twice daily) 1, 6
    • Low-dose NSAIDs 1
    • Low-dose prednisone (<10 mg/day) if colchicine and NSAIDs are contraindicated 1
  • Continue prophylaxis for at least 6 months, or 3 months after achieving target serum urate if no tophi are present, or 6 months after achieving target serum urate if tophi are present 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gout Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Polyarticular Gout Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute and Chronic Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.